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are to the first daily CBCT and the planning CT. Water 
equivalent path lengths and doses to the PTVs using a 3D 
gamma analysis were analyzed. Additional phantom 
experiments were conducted to evaluate mild deformations 
simulating weight gain/loss and rectal filling/draining. 
Results: For the phantom tests, uncorrected CBCT 
reconstructions had the largest HU value differences 
compared to the reference CT while the a priori scatter 
corrected CBCT reconstruction had the most accurate HU 
values. Regarding WEPL, the uncorrected CBCT had average 
of errors of 5-13 mm depending upon the phantom size and 
herterogeneities. A uniform scatter corrected CBCT had 
average range error of 3-22 mm and the a priori scatter 
corrected CBCT had average range errors of 1-3 mm (See 
Table). All WEPL errors were calculated using the refence CT 
of the phantoms. Doses were calculated in the same 
phantoms using targets simulating realistic clinical scenarios 
and beam combinations routinely used in the clinic. Gamma 
pass rates for 2%/2mm and 3%/3mm were always highest for 
the a priori scatter corrected CBCT at 96% and 99%, 
respectively. For uniform corrected CBCT dose calculations, 
the gamma pass rates were 78% (2%/2mm) and 86% (3%/3mm) 
with the worst cases being in the thorax due to an 
overestimation of the uniform scatter model with less 
attenuation and scatter in the lung. Patient doses were 
calculated with similar gamma pass rates but gamma rates 
varied more due to the realistic presence of patient daily 
variations of shape, target position and deformation of 
internal anatomy (see Figure for Prostate Example).  
 
 
Conclusions: Daily CBCT can be used for daily proton dose 
and range calculations for adaptive proton therapy when 
using an a priori scatter correction method. WEPL errors have 
been reduced from 13 mm to 3 mm and dose calculations can 
be performed with gamma 2%/2mm errors of less than 4%. 
Deformations due to weight gain/loss and target motion can 
be assessed with the proposed reconstruction methods. 
Further refinements in the CBCT reconstruction accounting 
for beam hardening and HU calibration specificity can reduce 
the range error below 3 mm.  
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Purpose/Objective: A concern with the use of VMAT in 
hypofractionated lung treatments is whether tumour motion 
will lead to significant discrepancies between calculated and 
planned dose distributions. Our study aimed at: 
a) Evaluating whether planning on the average CT scan (AVG 
CT) allows for a good representation of the dose distribution 
delivered to the moving target when 'interplay' is not 
considered; 
b) Quantifying the interplay effect between tumour motion 
and dose delivery using a moving phantom and GafChromic 
EBT3 films. 
Materials and Methods: 
Patients 
For ten patients who received lung treatment (54 Gy in 3 
fractions), VMAT plans generated with Monaco TPS on the 
AVG CT were recalculated on each phase of the 4DCT and the 
resulting plans were compared. A Philips BigBore CT scanner 
was used to acquire and reconstruct images (retrospective 
method based on phase detection). All patients had an ITV 
defined using the maximum intensity projection (MIP). A PTV 
was created as a 5 mm isotropic expansion of the ITV.  
Phantom 
A motor driven moving phantom was customized with an add-
on device consisting of a circular 3 cm diameter tissue 
equivalent sphere in polystyrene. The phantom moves in the 
cranio-caudal direction (2 cm peak-to-peak), with a 
frequency of 15 cycles/min and with an 'inspiration' phase 
shorter than the 'expiration' phase. EBT3 films can be 
inserted in the sphere simulating the target. 
Plans were generated on the AVG CT in two different ways: 
1) with no density override and 2) setting the ITV density to 
the mean GTV density and the PTV-ITV shell to an 
intermediate density between lung and GTV. The density 
override was performed with the further aim of reducing the 
dose distribution modulation that is induced by the 
difference in density between ITV and PTV-ITV, but which is 
neither intentional nor desired. 
In order to single out the interplay effect, plans were also 
generated optimizing and prescribing to the ITV only (both 
with and without density override). 




In Table the results of the patient plan are reported, showing 
moderate variations between the AVG CT plan and the plans 
recalculated on each phase of the 4DCT. None of the 
parameters shows any statistically significant correlation 
between the variation and the extent of tumour 
displacement. 




When the dose verification is performed on moving 
phantoms, an average deterioration of the gamma passing 
rates of 20% is observed compared to the verification in static 
phantom. The plans optimized with densities override did not 
show an improved agreement between dose and calculation 
in moving phantom (Figure). 
 
 
Conclusions: The average CT is adequate for planning only as 
a first approximation, as significant interplay effects 
between the target motion and the intensity modulated dose 
delivery exist. The agreement between planned and 
measured dose distribution does not improve when density 
overrides in the ITV and PTV regions are applied. 
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Purpose/Objective: Deformable registrations of medical 
images are becoming widely used for both radiotherapy 
optimization, but also for treatment response evaluation, 
e.g. defining relapses. However, the accuracy of deformable 
image registration (DIR) is rarely validated. The current study 
evaluates the accuracy of the open source deformable 
registration tool elastix when used for registration of 
different organ structures on planning CT and relapse CT 
scans of head and neck patients. 
Materials and Methods: Twenty patients treated with 
definitive IMRT for oral cavity, oropharynx and hypopharynx 
cancer in 2010-2012 were retrospectively and randomly 
included in the study. For each patient a planning CT and a 
diagnostic relapse CT scan were used (CT voxels were 3 mm 
in the cranio-caudal (CC) direction and 1 mm in the in-plane 
directions). 
One observer manually contoured 8 organs (spinal cord, 
mandible, right/left parotid and submandibular glands, 
thyroid gland and vertebrae C3-5) on planning CT (pCT), 
relapse CT (rCT) and re-delineated again on the planning CT 
(reCT).  
The contouring on the relapse CT was mapped to the 
planning CT using elastix (http://elastix.isi.uu.nl/). Spatial 
analysis of the difference in ROI delineation was performed 
by measuring the minimum distance between the two ROI’s 
on each surface point of the original ROI. For each ROI the 
combined uncertainty of DIR and delineation was calculated 
as the standard deviation of the minimum surface distances. 
Organ type specific uncertainties were calculated as Root-
Mean-Square (RMS) of the patient individual standard 
deviations. 
Re-delineation was used as a baseline for the obtainable 
uncertainty. Spearman’s correlation between uncertainties of 
re-delineation and deformed delineation was performed to 
check whether delineation uncertainty influenced the 
outcome of the deformable results.  
Results: Surface plot of the spatial resolved deviation showed 
that the largest deviations where mainly in the CC direction 
(areas where the ROI surface normal primarily is in the CC 
direction) (left submandibular gland as an example, picture). 
RMS values for re-delineation and DIR are shown in table. 
A significant but low correlation exists between the ROI 
uncertainty of individual re-delineation and deformable 
contours (R=0.23, p=0.004). Thus a part of the deformable 
uncertainties are related to uncertainty of the manual ROI 
delineation. Significant correlations within single organs were 
not found. 
